HMS Holdings (HMSY) Beats Q3 by 2c; Raises Guidance
More News related to HMSY
- HMS Holdings Corp. to Present at Investor Conferences
- Jefferies & Co Maintains a 'Buy' on HMS Holdings (HMSY); Raises Price Target
- HMS Holdings (HMSY) Beats Q3 by 2c; Raises Guidance
- HMS Holdings Corp. Announces Third Quarter 2009 Results; 2009 Revised Guidance and Initial 2010 Guidance
- Trading Radar for 10/30: Sony (SNE), Penske (PAG), Alcatel-Lucent (ALU) Report
More News related to Earnings
- RW Baird Makes Positive Comments on Incyte (INCY) Following Novartis Deal
- Incyte (INCY) Strikes Major Drug Development Deal with Noavartis
- Human Genome Sciences (HGSI) Submits BLA to U.S. FDA for Hep C Treatment ZALBIN
- Incyte (INCY) In License Agreement With Novartis, Worth Up to $1 Billion
- Gen-Probe (GPRO) Gets U.S. FDA Clearance for Marketing Prodesse's ProParaflu+ Assay
HMS Holdings Corp (NASDAQ: HMSY) reports Q3 EPS of $0.30, 2 cents better than the analyst estimate of $0.28. Revenue for the quarter was $59.16 million, which compares to the estimate of $57.49 million.
Raises FY09 guidance. Now sees FY09 revs of $228.50 million, from 222 million. FY09 EPS from $1.05 to $1.08.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
